首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Immunopharmacology And Immunotoxicology

Immunopharmacology And Immunotoxicology杂志,由Informa Healthcare出版,于1987年创刊,Quarterly,出版语言English,ISSN:0892-3973,E-ISSN:1532-2513。

投稿咨询
Immunopharmacology And Immunotoxicology
Immunopharmacology And Immunotoxicology
Immunopharmacology And Immunotoxicology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.1
CiteScore
5.3
期刊收录
SCI、SCIE

Immunopharmacology And Immunotoxicology(中文译名:《免疫药理学和免疫毒理学》),ISSN:0892-3973,EISSN:1532-2513,是Informa Healthcare出版的国际性学术期刊,创刊于1987年,以Quarterly形式稳定发行,2026年总发文量约77篇。该刊采用非OA开放访问,学科归属为医学 - 毒理学。该刊是医学、免疫学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.1,2025年期刊CiteScore为5.3,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Immunopharmacology And Immunotoxicology长期聚焦医学、免疫学及相关产业的技术应用前沿,平均审稿周期偏慢,4-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、免疫学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDIran、India、South Korea、USA、Brazil、Turkey等为核心发文国家与地区;TEHRAN UNIVERSITY OF MEDICAL SCIENCESIRAN UNIVERSITY OF MEDICAL SCIENCES、KYUNG HEE UNIVERSITY、SHAHID BEHESHTI UNIVERSITY MEDICAL SCIENCES、BENI SUEF UNIVERSITY、BHARATI VIDYAPEETH DEEMED UNIVERSITY、HOSEO UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学
3区 3区 3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学
4区 4区 4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
TOXICOLOGY 毒理学 IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学
3区 4区 4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q3 108 / 183

41.3

学科:PHARMACOLOGY & PHARMACY SCIE Q2 163 / 356

54.4

学科:TOXICOLOGY SCIE Q2 52 / 106

51.4

学科:IMMUNOLOGY SCIE Q2 68 / 183

63.11

学科:PHARMACOLOGY & PHARMACY SCIE Q2 113 / 356

68.4

学科:TOXICOLOGY SCIE Q2 39 / 106

63.68

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q3 93 / 183

49.5

学科:PHARMACOLOGY & PHARMACY SCIE Q2 138 / 352

60.9

学科:TOXICOLOGY SCIE Q2 45 / 106

58

学科:IMMUNOLOGY SCIE Q2 70 / 183

62.02

学科:PHARMACOLOGY & PHARMACY SCIE Q2 118 / 353

66.71

学科:TOXICOLOGY SCIE Q2 42 / 106

60.85


中国学者近期发文

1
Thymosin α1 improves the outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure by restoring immune balanc

Author:Li, Zhi-hui; Wu, Li-li; Zhu, Yuan-qiang; Hu, Zhao-xia; Meng, Shi-bo; Lei, Zi-ying; Cao, Hui-juan; Wang, Jia-lei; Chen, Jun-feng; Zhang, Jing; Lin, Bing-liang

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2026; Vol. 48, Issue 2, pp. 341-353. DOI: 10.1080/08923973.2026.2641686

2
Clinical features, treatment, and outcomes of anti-PD-1/PD-L1 immune checkpoint inhibitors induced dermatomyositi

Author:Xiao, Jian; Xia, Zhi; Yang, Fengrui; Liao, Siwei; Fang, Min

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2026; Vol. 48, Issue 2, pp. 354-361. DOI: 10.1080/08923973.2026.2638325

3
Comprehensive pharmacovigilance analysis of lebrikizumab: a real-world safety assessment based on the FDA Adverse Event Reporting System (FAERS) databas

Author:Chen, Maohua; Ke, Chengjie; Huang, Yaping

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/08923973.2026.2648209

4
The dual potential of topical roflumilast: advancing psoriasis therapy and pioneering oral mucosal disease treatmen

Author:Sun, Junwei; Shi, Fan; Li, Lingling

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/08923973.2026.2615403

5
Vitamin D inhibits the development of colorectal cancer cells by regulating the gut microbiota and immune microenvironment using JAKSTAT signaling pathwa

Author:Bai, Geyan; Tao, Yinglong; Fan, Min

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/08923973.2026.2630162

6
Breviscapine inhibits the proliferation and immune escape of diffuse large B-cell lymphoma cells by regulating JAK2/STAT3/PD-L1 pathwa

Author:Zhong, Xiamin; Chen, Juanjuan; Jiang, Bo; Zeng, Yan; Du, Chuanqing

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/08923973.2026.2632299

7
Nodakenin attenuates cerebral ischemia-reperfusion injury by modulating the PI3K/AKT/NF-κB signaling pathwa

Author:Zhang, Xudong; Yang, Gang; Liang, Chao; Li, Yanji; Gao, Longlan; Liu, Yu; Wang, Yue; Li, Jinjian; Zhou, Yangyang; Han, Zhuohang; Ren, Jixiang

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/08923973.2026.2638327

8
Alpha7 nicotinic acetylcholine receptor participates in the effect of dexmedetomidine on Treg cell differentiatio

Author:Wang, Yulan; Yang, Xiaoyan; Kong, Xiaoqi; Gong, Huanle; Lei, Yishan; Ji, Fuhai

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/08923973.2026.2640188

9
Kindlin-2 silencing promoted apoptosis and cell cycle arrest through the fas/FasL pathway in hepatocellular carcinom

Author:Yu, Weiwei; Wang, Yan; Wang, Shugang

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2025; Vol. 47, Issue 3, pp. 429-439. DOI: 10.1080/08923973.2025.2506696

10
Effects of infliximab infusion on clinical symptom scores and serum cytokines in patients with inflammatory bowel diseas

Author:Tan, Wei; Wang, Hao; Guo, Hong

Journal: IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 2025; Vol. 47, Issue 3, pp. 419-428. DOI: 10.1080/08923973.2025.2504908


在线咨询

Immunopharmacology And Immunotoxicology

国际简称:IMMUNOPHARM IMMUNOT参考译名:免疫药理学和免疫毒理学

年发文量:77 CiteScore:5.3 是否预警:否 Gold OA文章占比:1.83% 研究类文章占比:89.61%

杂志社联系方式:TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106

Immunopharmacology And Immunotoxicology